Pharmacokinetic profile of recombination human insulin-like growth factor binding protein-1 in athymic mice

Biomedicine and Pharmacotherapy

Volumn 50, Issue 3-4, 1996, Pages 154-157

  Yee, D ^a   Van Den Berg, C L ^a   Kozelsky, T W ^a   Kuhn, J G ^c   Cox, G N ^b  

^a Univ of Texas Health Science Center ^*  (United States)

^b AMGEN INC   (United States)

^c NONE

Author keywords

insulin like growth factor; insulin like growth factor binding protein; pharmacokinetic

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; MOUSE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029977167     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/0753-3322(96)85290-5     Document Type: Article

References (9)

1. Myal Y, Shiu RPC, Bhaumick B, Bala M. Receptor binding and growth-promoting activity if insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res 1984;44:5486
2. Osborne CK, Coronado EB, Kitten LJ et al. Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 1989;3:1701
3. Yee D, Cullen KJ, Paik S et al. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 1988;48:6691
4. Cullen KJ, Yee D, Sly WS et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990;50:48
5. Arteaga CL, Kitten LJ, Coronado EB Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 1989; 84:1418
6. Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-1, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. J Cell Physiol 1993;157:229
7. Young SCJ, Miles MV, Clemmons DR. Determination of the pharmacokinetic profiles of insulin-like growth factor binding protein-1 and protein-2 in rats. Endocrinology 1992;131:1867
8. Hossenlopp P, Seurin D, Seovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting; use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986;154:138
9. Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics, 3rd ed. Philadelphia: Lea & Febiger, 1984:17